文献速递生殖医学

体外受精结局的临床预测模型:系统综述、Meta分析与外部验证

Clinical prediction models for in vitro fertilization outcomes: a systematic review, meta-analysis, and external validation.
PubMed 文献 · Hum Reprod · 2025-01-01

该研究系统检索PubMed、EMBASE和Web of Science截至2024年4月3日的英文文献,纳入72项研究、132个预测因子和86个预后模型,对5个选定模型进行Meta分析,并在中国队列中对其中4个模型做外部验证。McLernon治疗后模型在Meta分析(AUC 0.73,95%CI 0.71-0.75)和外部验证中表现最优。

要点

  • McLernon治疗后模型在Meta分析中AUC为0.73(95%CI 0.71-0.75),优于其他选定模型。
  • 外部验证中初始四个模型的AUC范围为0.53至0.58,校准通过校准图确认。
  • 纳入72项研究总体偏倚风险为高或不明确,共含132个预测因子和86个预后模型。

核心结论

  • 在已识别的预后模型中,McLernon的治疗后模型在Meta分析和中国队列外部验证中均优于其他模型。
  • 本研究为体外受精预测模型领域的首个Meta分析,明确证实McLernon治疗后模型的优越性能,但需进一步研究开发新模型并外部验证现有高性能模型。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、EMBASE和Web of Science截至2024年4月3日的英文文献。
  • 纳入报告模型特征清晰的体外受精活产结局预后模型开发或验证研究,共72项研究。
  • 从纳入研究中提取132个预测因子和86个预后模型,对5个选定模型分别进行Meta分析。
  • 在中国队列中对初始四个模型进行外部验证,注册号2022 CRD42022312018。

主要发现

  • Templeton模型随机效应合并AUC为0.65(95%CI 0.61-0.69)。
  • Nelson模型随机效应合并AUC为0.63(95%CI 0.63-0.64)。
  • McLernon治疗前模型随机效应合并AUC为0.67(95%CI 0.62-0.71)。
  • McLernon治疗后模型随机效应合并AUC为0.73(95%CI 0.71-0.75)。
  • 智能数据分析评分(iDAScore)模型固定效应合并AUC为0.66(95%CI 0.63-0.68);初始四个模型在中国队列外部验证的AUC范围为0.53至0.58,校准通过校准图确认。

关键数值与推荐

  • 纳入72项研究总体偏倚风险为高或不明确。
  • Meta分析中模型效应选择基于I2统计量和Cochrane Q检验评估的异质性。
  • 模型性能通过受试者工作特征曲线下面积(AUC)和校准图评估。

临床怎么用

  • 作者指出,聚焦英文研究和活产结局可能限制 findings 对多样人群的普适性,但为以活产为最终目标的临床医生提供了更精确可操作的参考指南。

局限性

  • 聚焦英文语言研究和活产结局可能限制研究结果对多样人群的普适性。
  • 纳入研究的总体偏倚风险为高或不明确。
  • 需进一步研究开发新模型并外部验证现有高性能模型的预后准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the best-performing model currently predicting live birth outcomes for IVF or ICSI? SUMMARY ANSWER: Among the identified prognostic models, McLernon's post-treatment model outperforms other models in both the meta-analysis and external validation of a Chinese cohort. WHAT IS KNOWN ALREADY: With numerous similar models available across different time periods and using various predictors in IVF prognostic models, there is a need to summarize and evaluate them, due to a lack of validated evidence distinguishing high-quality from low-quality prediction tools. However, there is a notable dearth of research in the form of meta-analysis or external validation assessing the performance of models in predicting live births in this field. STUDY DESIGN, SIZE, DURATION: The researchers conducted a comprehensive literature review in PubMed, EMBASE, and Web of Science, using keywords related to prognostic models and IVF/ICSI live birth outcomes. The search included studies published up to 3 April 2024, and was limited to English language studies. PARTICIPANTS/MATERIALS, SETTING, METHODS: The review included studies that developed or validated prognostic models for IVF live birth outcomes while providing clear reports on model characteristics. Researchers extracted and analysed the data in accordance with the guidelines outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses and other model-related guidelines. For model effects in meta-analysis, the choice would be based on the heterogeneity assessed using the I2 statistic and the Cochrane Q test. Model performance was evaluated by assessing their area under the receiver operating characteristic curves (AUCs) and calibration plots in the studies. MAIN RESULTS AND THE ROLE OF CHANCE: This review provides a comprehensive summary of data derived from 72 studies with an overall ROB of high or unclear. These studies contained a total of 132 predictors and 86 prognostic models, and then meta-analyses were performed for each of the five selected models. The total random effects of Templeton's, Nelson's, McLernon's pre-treatment and post-treatment model demonstrated AUCs of 0.65 (95% CI: 0.61-0.69), 0.63 (95% CI: 0.63-0.64), 0.67 (95% CI: 0.62-0.71), and 0.73 (95% CI: 0.71-0.75), respectively. The total fixed effects of the intelligent data analysis score (iDAScore) model estimated an AUC of 0.66 (95% CI: 0.63-0.68). The external validation of the initial four models in our cohort produced AUCs ranging from 0.53 to 0.58, and the calibration was confirmed through calibration plots. LIMITATIONS, REASONS FOR CAUTION: While the focus on English-language studies and live birth outcomes may constrain the generalizability of the findings to diverse populations, this approach equips clinicians, who view live births as the ultimate objective, with more precise and actionable reference guidelines. WIDER IMPLICATIONS OF THE FINDINGS: This study represents the first meta-analysis in the field of IVF prediction models, definitively confirming the superior performance of McLernon's post-treatment model. The conclusion is reinforced by independent validation from another perspective. Nevertheless, further investigation is warranted to develop new models and to externally validate existing high-performing models for prognostic accuracy in IVF outcomes. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the National Natural Science Foundation of China (Grant No. 82174517). The authors report no conflict of interest. REGISTRATION NUMBER: 2022 CRD42022312018.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Tian CH, Liu LY, Huang YF, et al. Clinical prediction models for in vitro fertilization outcomes: a systematic review, meta-analysis, and external validation. Hum Reprod. 2025. PMID: 39983753. doi:10.1093/humrep/deaf013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。